Assembly Biosciences Doses First Participant in Phase 1B Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate Abi-4334 for the Treatment of Chronic Hepatitis B Virus Infection
assembly biosciences開始第一位參與慢性乙肝病毒感染下一代衣殼裝配調節劑候選藥物Abi-4334的1B期臨床試驗